Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$37,097,950
+$2,396,691 QoQ
Shares Held
288,700
+0.1% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#375
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $287,466,952 across 14 Drug Manufacturers - General names. MRK ranks #2 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
104,112 | $124,875,066 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
288,700 | $37,097,950 | |
| 3 | JNJ |
Johnson & Johnson
|
127,317 | $32,334,698 | |
| 4 | AMGN |
Amgen Inc
|
55,700 | $20,170,084 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
256,790 | $14,796,239 | |
| 6 | ABBV |
AbbVie Inc.
|
53,250 | $13,399,830 | |
| 7 | OGN |
Organon & Co.
|
954,910 | $12,929,481 | |
| 8 | PFE |
Pfizer Inc
|
501,500 | $12,076,120 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,097,950 | 288,700 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $34,701,259 | 288,480 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $32,005,881 | 304,065 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $27,314,179 | 325,440 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $25,815,263 | 326,115 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $31,381,442 | 349,615 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $35,236,313 | 354,205 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $38,056,340 | 335,121 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $39,364,190 | 317,966 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $40,279,188 | 305,261 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $34,044,329 | 312,276 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $33,844,915 | 328,751 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $39,310,026 | 340,671 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $38,003,678 | 357,211 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $41,345,628 | 372,651 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $36,698,295 | 402,526 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $36,153,363 | 440,626 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $35,147,180 | 458,601 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $37,907,265 | 504,690 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $38,898,220 | 500,170 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $38,504,163 | 499,470 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $41,782,603 | 510,790 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $38,562,643 | 464,890 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $35,114,021 | 454,080 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $49,770,926 | 646,880 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||